BRS Analytical Services, LLC is recalling approximately 75,795 units of several types of AvKARE brand eye lubricants, including Artificial Tears (dextran 70.01%/glycerin 0.2%/hypromellose 0.3%) and various formulations of carboxymethylcellulose sodium, polyethylene glycol, and polyvinyl alcohol. The recall was initiated due to manufacturing violations and a lack of assurance that the products are sterile. Using non-sterile eye drops can lead to serious eye infections that may cause vision loss. These products were sold in 0.5 FL OZ dropper bottles and were distributed nationwide across the United States.
Products intended for use in the eyes that are not sterile pose a significant risk of infection, as bacteria or other contaminants can be introduced directly to the eye. While no specific injuries have been reported, the lack of sterility assurance means the safety and quality of these eye lubricants cannot be guaranteed.
You have 2 options:
Distributed by: AvKARE, Pulaski, TN 38478
Distributed by: AvKARE, Pulaski, TN 38478
Distributed by: AvKARE, Pulaski, TN 38478
Distributed by: AvKARE, Pulaski, TN 38478
Distributed by: AvKARE, Pulaski, TN 38478
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.